A Multicenter, Open-label, Phase 2 Study of Imprime PGG and Pembrolizumab in Patients with Metastatic Breast Cancer (mBCA) Who Have Progressed Through Prior Hormonal Therapy

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Type of Study

Treatment

Locations

CTRC Inpatient
Lone Tree Medical Center
University of Colorado Hospital

Principal Investigator
Photograph of Peter Kabos,  MD

Peter Kabos, MD

Study ID

Protocol Number: 21-5099

More information available at ClinicalTrials.gov: NCT05159778

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers